Overview

A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
- Determine whether VI-0521 has an effect on the electrical activity of the heart in healthy subjects. - Find out how much VI-0521 is in the blood and any potential side effects on ECG's of healthy subjects after taking the study drugs.
Phase:
Phase 1
Details
Lead Sponsor:
VIVUS, Inc.